Our local DOT drug and alcohol testing centers are located in Fair Oaks AR and the surrounding areas providing DOT drug testing, DOT alcohol testing and DOT physicals for all DOT modes regulated by Part 40. Same day service is available at our Fair Oaks AR DOT drug testing facilities and most of our DOT drug testing locations are within minutes of your home or office.
What type of DOT Testing is required?
Coastal Drug Testing provides DOT pre-employment, random, post-accident, reasonable suspicion and return to duty testing at our Fair Oaks AR DOT drug testing centers.
If you hold a CDL license, a large, medium or a small trucking company, Coastal Drug Testing has a complete DOT compliance package which includes all the requirements to comply with CFR 49 part 40.
All Coastal Drug Testing DOT drug testing centers utilize SAMHSA Certified laboratories and a licensed Medical Review Officer as required by DOT part 40 regulations.
The U.S Department of Transportation (DOT) requires that all DOT regulated "safety sensitive" employees have a negative DOT pre-employment drug test result on file and be actively enrolled in a DOT approved random drug and alcohol random testing pool (consortium).
In addition, if a DOT regulated company has more than one "safety sensitive" employee, the employer must also have a written DOT drug and alcohol policy along with an on-site supervisor that must have completed a reasonable suspicion supervisor training program.
On the road and need a DOT Drug or Alcohol test? No Worries!
To be compliant with DOT regulations, a company's DOT drug and alcohol testing program must have the following components:
- Employee Drug Testing
- Written Drug and Alcohol Policy
- Supervisor Training
- Substance Abuse Referral
- Employee Education
- Random Selection Program
- Post Accident Testing
- Designated Employer Representative
- Federal Chain of Custody Forms
- Part 40 Regulations on File
The Department of Transportation (DOT) has specific drug and alcohol testing requirements for the all transportation modes all DOT agencies.
Our modes included are:
- Federal Motor Carrier Safety Administration (FMCSA)
- Federal Aviation Administration (FAA)
- Federal Transit Administration (FTA)
- United States Coast Guard (USCG)
- Pipeline and Hazardous Materials Safety Administration (PHMSA)
- Federal Railroad Administration (FRA)
Are You Enrolled in a DOT Consortium?
Individuals who are employed in a position designated as "safety sensitive" must be actively enrolled in a random drug and alcohol testing program. Oftentimes, covered employees will join a group of other DOT regulated employees in a random testing program and this is referred to as a DOT Consortium. Generally, an employer who has less than fifty employees or single operators will join the consortium which will comply with the random drug and alcohol testing requirements of 49 CFR Part 40. Employers that have over 50 employees who are regulated by Part 40 may elect to be enrolled in a "stand alone" random testing pool.
The DOT consortium is cost effective and complies with all requirements of 49 CFR Part 40 which mandates that all "safety sensitive" employees be enrolled in a random drug and alcohol testing program.
The Department of Transportation (DOT) has strict regulations requiring regulated companies and independent operators (CDL License Holders) to be an active member of a DOT drug and alcohol Consortium and failure to comply with these regulations can result in significant fines and other DOT sanctions.
We are fully versed in the DOT procedures for pre-employment drug testing, random drug testing, reasonable suspicion drug testing, post-accident drug testing, return to duty drug testing and follow up drug testing.
DOT regulated companies with multiple safety sensitive employees must also have an employee within the company who is assigned as the "designated employer representative" (DER). This is the person responsible for removing any DOT "safety sensitive" employee who is covered by 49 CFR Part 40 from performing a DOT safety sensitive position when a positive drug or alcohol test result has occurred or an employee has refused to take a required DOT test.
If you have recently become a DOT regulated company, within the next 18 months the Department of Transportation (DOT) will conduct a "new entrant" inspection to ensure that you are in compliance with all DOT regulations including the drug and alcohol testing requirements. If you are currently a DOT regulated company, you are subject to regular inspections to ensure compliance.
Avoid DOT fines, penalties and be complaint with all DOT drug and alcohol testing regulations! Coastal Drug Testing can assist small, medium and large DOT companies in complying with all requirements of 49 CFR Part 40.
DOT Drug Testing Locations in Fair Oaks AR
801 N EDMONDS AVE 7.4 miles
MCCRORY, AR 72101
701 JULIA AVE E 14.0 miles
WYNNE, AR 72396
1901 KILLOUGH RD N 14.5 miles
WYNNE, AR 72396
623 N 9TH ST 18.7 miles
AUGUSTA, AR 72006
332 E COOK ST 19.9 miles
FORREST CITY, AR 72335
904 HOLIDAY DR STE 400 20.1 miles
FORREST CITY, AR 72335
902 HOLIDAY DR STE 103 20.1 miles
FORREST CITY, AR 72335
921 HOLIDAY DR 20.1 miles
FORREST CITY, AR 72335
1601 NEW CASTLE RD 20.5 miles
FORREST CITY, AR 72335
125 OAK St 20.8 miles
COTTON PLANT, AR 72036
(Don't see a location near you? Call us (800) 828-7086)
Local Area Info: James L. Cox
James L. Cox (born 24 December 1942, Fair Oaks, AR) is an American cardiothoracic surgeon and medical innovator best known for the development of the Cox maze procedure for treatment of atrial fibrillation in 1987.
James Cox started his college education on a baseball scholarship at the University of Mississippi. On the day he received an offer to play professional baseball with the Los Angeles Dodgers he also received his acceptance to medical school at the University of Tennessee. He wanted to be a surgeon, so he chose medical school. He received his MD from Tennessee and began his surgical residency at Duke University in 1967. He served with the US Army medical corps from 1970 through 1972, then returned to Duke to finish his residency and surgical training, under the direction of David Sabiston. He join the faculty as an assistant professor of surgery in 1978.
Cox advanced to associate professor of surgery at Duke in 1982, then in 1983 he moved to the Washington University School of Medicine in St. Louis, where he became Professor and Chief, CardioThoracic Surgery. Specializing in surgeries for cardiac arrhythmias, in 1987 he first performed his eponymous "maze" procedure, which was recognized as the first cure for atrial fibrillation. From 1990 to 1997 he was Evarts A. Graham Professor of Surgery at Washington University.